Capstone Investment Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Capstone Investment Advisors's ABMD Position: Q4 2022 in Review
Capstone Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 667 shares — an estimated $164K sold.
Capstone Investment Advisors first reported a position in ABMD in Q2 2017 and held it in 9 quarters. The position peaked at $4.57M in Q2 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Capstone Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Capstone Investment Advisors sold 667 Abiomed Inc shares in Q4 2022, an estimated $164K.
- Capstone Investment Advisors first reported a position in Abiomed Inc in Q2 2017 and held it in 9 quarters.
- Capstone Investment Advisors's Abiomed Inc position peaked at $4.57M in Q2 2017.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Capstone Investment Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.